Sarah Kaplan Browne - 12 Oct 2026 Form 4 Insider Report for MetaVia Inc. (MTVA)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
13 Oct 2026, 16:06:18 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Phillip Torrence, by Power of Attorney
Filing notes and source

Key filing fact

Sarah Kaplan Browne filed Form 4 for MetaVia Inc. (MTVA) on 13 Oct 2026.

Key facts

  • This page summarizes Sarah Kaplan Browne's Form 4 filing for MetaVia Inc. (MTVA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 13 Oct 2026, 16:06.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002158844 Primary reporting owner

Browne Sarah Kaplan

Relationship
Chief Medical Officer
Address
C/O METAVIA INC., 545 CONCORD AVENUE, SUITE 210, CAMBRIDGE
Signature
/s/ Phillip Torrence, by Power of Attorney
Signature date
13 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTVA transaction

Common Stock

Award

Transaction value
Shares
+53,000
Change %
Price
$0.000000*
Shares after
53,000
Date
12 Oct 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests as to 50% on each of the first and second anniversaries of the date of grant, subject to the Reporting Person's continuing service on the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .